S-1/AS-1/A
May 29, 2026Amended0001493152-26-026355
All companies
Start with eToroBioVentrix S-1/A filed May 15, 2026
Bioventrix Inc
IPO Upcoming
IPO UpcomingUnited States0 markets
Official IPO
Filed· Listing market: United StatesExpected IPO date
To be announced
Final IPO price
To be announced
Shares offered
To be announced
IPO raise
To be announced
Sources: sec-edgar, sec-harvest
No live market is quoted for Bioventrix Inc yet. Get in line for IPO-day access through a broker in the meantime.
eToro
Invest in stocks once they list with eToro
Trade stocks, ETFs and crypto from one simple account.
About Bioventrix Inc
Bioventrix Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Bioventrix Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
AmendedEDGAR filings resolved from 0001283259 / CIK 0001283259.
S-1/AS-1/A
May 15, 2026Amended0001493152-26-023752
S-1/AS-1/A
Mar 18, 2026Amended0001493152-26-010642
S-1S-1
Feb 12, 2026Filed0001493152-26-006407
DRS/Afilename1.htm
Dec 12, 2025Confidential draft0001493152-25-027406
DRS/Afilename1.htm
Oct 6, 2025Confidential draft0001493152-25-016953
Aug 5, 2025Confidential draft0001641172-25-022123
Latest Bioventrix Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
SECMay 15, 2026IPO filing
BioVentrix filed Amendment No. 2 to its Form S-1 on May 15, 2026, updating its IPO registration statement with the SEC. The filing states this is the company’s initial public offering and that it is seeking Nasdaq Capital Market listing under BVXX.
Bioventrix Inc IPO — frequently asked questions
- When is Bioventrix Inc's IPO?
- Bioventrix Inc has not announced an official IPO date yet — it is still privately held. We update this page as soon as an IPO date, filing or price range is reported.
- What is Bioventrix Inc's expected IPO price?
- Bioventrix Inc's IPO price has not been set yet. The price range is usually disclosed in the final prospectus, shortly before the company lists.
- Is Bioventrix Inc publicly traded?
- Not yet — Bioventrix Inc is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Bioventrix Inc's pre-IPO price and IPO date will appear here as soon as they're available.